*Actual product packaging may differ from the image shown.
MOTS-C
MOTS-c is a mitochondrial-derived peptide designed to support cellular energy production, metabolic flexibility, and stress resilience. Unlike traditional metabolic peptides, MOTS-c works directly at the mitochondrial level to help cells adapt to metabolic stress, improve glucose and fat utilization, and support overall cellular efficiency. By enhancing how the body produces and uses energy, MOTS-c supports metabolic health, endurance, and long-term resilience from the inside out.
Protocols developed under the clinical direction of Dr. Jonathann Kuo, MD
Select Size:
What happens after checkout
- ①Purchase your treatment
- ②Complete your Qualiphy consultation via email (~3 min)
- ③Licensed provider reviews & approves your prescription
- ④Pharmacy ships within 3–5 days of approval
After checkout, you'll receive an email to complete your telehealth consultation. A licensed provider must approve before your order ships.
Potential benefits may include:
- Supports mitochondrial function and cellular energy production
- Improves metabolic flexibility and glucose utilization
- Enhances fat metabolism and metabolic efficiency
- Supports endurance, exercise capacity, and physical resilience
- Helps the body adapt to metabolic and oxidative stress
- May support cognitive clarity and overall vitality
- Pregnancy or Breastfeeding: Safety has not been established; use is not recommended.
- Active Cancer or Recent Cancer Treatment: Mitochondrial and metabolic peptides are generally avoided unless specifically directed by a provider.
- Known Allergy: Avoid use if you have a sensitivity to peptide-based therapies or formulation components.
Mild, short-term effects may occasionally occur, especially when first starting, including:
- Temporary redness, tenderness, or itching at the injection site
- Flushing, warmth, or mild skin redness, which can occur as mitochondrial and metabolic signaling increases
- Occasional mild rash or skin sensitivity, typically transient and dose-dependent
- Mild headache or light fatigue as cellular energy pathways adjust
- Temporary changes in appetite or energy levels
These effects are usually mild and resolve as the body adapts. Because MOTS-c directly affects mitochondrial signaling, starting at a lower dose and gradually increasing is recommended to assess individual tolerance and minimize side effects.
For safe and informed use, review the Extension Health Injection Reaction Guide (PDF), which outlines what to expect, how to reduce discomfort, and when to seek medical support.
- Weeks 1–2: MOTS-c begins signaling at the mitochondrial level to improve cellular energy production, glucose utilization, and metabolic flexibility. Early effects are primarily internal and metabolic rather than visible. Some patients notice subtle shifts in energy, warmth, exercise tolerance, or how their body responds to food and activity during this phase.
- Weeks 3–6: As mitochondrial signaling becomes more consistent, the body becomes more efficient at using both glucose and fat for fuel. Patients may begin to notice improvements in energy stability, endurance, workout recovery, and metabolic resilience, particularly when paired with nutrition and regular movement.
- Weeks 8–12: Sustained use supports ongoing mitochondrial efficiency and stress adaptation. More noticeable improvements in physical stamina, metabolic flexibility, body composition support, and overall vitality may occur during this phase. Benefits tend to build gradually, making MOTS-c well suited for metabolic health, energy support, and long-term resilience rather than immediate or dramatic changes.